ALTERITY THERAPEUTICS LTD (ATHE) Form 6-K — Oct 23, 2026

Alterity Therapeutics Limited, an Australia-based development-stage biotech, filed a Form 6-K on October 23, 2026 reporting a proposed issue of securities under Exhibit 99.1. The substantive exhibit content was submitted as an image, so offering terms such as size, price, and use of proceeds cannot be extracted from the filing text. For a development-stage enterprise, a proposed securities issuance typically signals a capital raise ahead, implying potential dilution for existing shareholders.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.